Continuing our successful continuing programme of pharmaceutical analysis symposia, this meeting will focus on cleaning validation and is aimed at providing the latest regulatory expectations and best practice information in the domain of cleaning validation since the publication of the European Medicines Agency Shared Facilities Guideline and subsequent Q&A Document.
The meeting will explore cleaning validation requirements from a toxicologists perspective and also examine new facility design considerations to minimise the potential for cross contamination.
There will be ample opportunity to interact with the expert speakers during Q&A sessions and panel discussions throughout the day and informally during lunch and refreshment breaks.
This symposium will be of special interest to those engaged in Quality Control and Quality Assurance , Manufacturing and Validation in the Pharmaceutical and Biotech Industry, NHS manufacturing units, Contract Manufacturing Organisations, consulting, academia, and anyone else concerned with the management and assessment of cleaning validation.
The meeting will explore cleaning validation requirements from a toxicologists perspective and also examine new facility design considerations to minimise the potential for cross contamination.
There will be ample opportunity to interact with the expert speakers during Q&A sessions and panel discussions throughout the day and informally during lunch and refreshment breaks.
This symposium will be of special interest to those engaged in Quality Control and Quality Assurance , Manufacturing and Validation in the Pharmaceutical and Biotech Industry, NHS manufacturing units, Contract Manufacturing Organisations, consulting, academia, and anyone else concerned with the management and assessment of cleaning validation.
